Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

461.37
Delayed Data
As of May 23
 +0.38 / +0.08%
Today’s Change
325.35
Today|||52-Week Range
464.40
+25.68%
Year-to-Date
Merck Presents Phase II Data on Chronic Cough Candidate
May 23 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Biogen Inks Deal to Boost Pipeline, Sangamo Soars on Pfizer De...
May 17 / Zacks.com - Paid Partner Content
Sanofi/Regeneron's Kevzara Gets FDA Approval for Arthritis
May 23 / Zacks.com - Paid Partner Content
Bull of the Day: Regeneron (REGN)
May 17 / Zacks.com - Paid Partner Content
Merck's HIV Drug Gets Positive CHMP Opinion for Higher Dose
May 22 / Zacks.com - Paid Partner Content
TransEnterix (TRXC) Reports Wider-than-Expected Loss in Q1
May 15 / Zacks.com - Paid Partner Content
Compugen (CGEN) Worth a Look: Stock Adds 10.4% in Session
May 22 / Zacks.com - Paid Partner Content
Bear of the Day: AMAG Pharmaceuticals (AMAG)
May 15 / Zacks.com - Paid Partner Content
Regeneron, Nuance Communications, Waste Management, Waste Connections and Republic Se...
May 17 / Zacks.com - Paid Partner Content
Medtronic (MDT) Wins FDA Approval for CRT-P SureScan Suite
May 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close460.99
Today’s open462.00
Day’s range458.79 - 464.25
Volume573,858
Average volume (3 months)918,683
Market cap$49.0B
Dividend yield--
Data as of 3:59pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+13.45%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+18.44%
P/E ratio55.8
Price/Sales8.79
Price/Book10.98

Competitors

 Today’s
change
Today’s
% change
SHPGShire-2.50-1.33%
BAXBaxter International...+0.27+0.47%
ZTSZoetis Inc+1.12+1.86%
VRTXVertex Pharmaceutica...-2.35-1.98%
Data as of 4:14pm ET, 05/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$3.18
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts